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a b s t r a c t
Pateamine A (Pat A) is a natural marine product that interacts speciﬁcally with the translation initiation
factor eIF4A leading to the disruption of the eIF4F complex. In the present study, we have examined the
activity of Pat A on the translation of Sindbis virus (SINV) mRNAs. Translation of genomic mRNA is
strongly suppressed by Pat A, as shown by the reduction of nsP1 or nsP2 synthesis. Notably, protein
synthesis directed by subgenomic mRNA is resistant to Pat A inhibition when the compound is added at
late times following infection; however, subgenomic mRNA is sensitive to Pat A in transfected cells or in
cell free systems, indicating that this viral mRNA exhibits a dual mechanism of translation. A detailed
kinetic analysis of Pat A inhibition in SINV-infected cells demonstrates that a switch occurs approxi-
mately 4 h after infection, rendering subgenomic mRNA translation more resistant to Pat A inhibition.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Translation of cellular and viral mRNAs can take place by a
number of mechanisms depending on the mRNA and the context
of its translation. The vast majority of cellular mRNAs contain a cap
structure at their 5ʹ end and are translated following the canonical
mechanism that involves the recognition of the cap structure by
the heterotrimeric factor eIF4F followed by the interaction of the
preinitiation 43S complex with the mRNA (Sonenberg and
Hinnebusch, 2009). The eIF4F complex is composed of the cap-
binding factor eIF4E, the helicase and ATPase enzyme eIF4A and
the scaffolding protein eIF4G (Gingras et al., 1999). Unwinding of
the secondary structure present in the mRNA leader sequence is
accomplished by eIF4AI or eIF4AII, which are functionally inter-
changeable isoforms with 90% similarity (Parsyan et al., 2011).
After RNA unwinding, the 40S ribosomal subunit containing
several initiation factors linearly scans the leader sequence until
an AUG codon is encountered in a good sequence context (Kozak,
1991). Initiation of translation can also occur by a mechanism
which is independent of the cap structure whereby initiation takes
place at an internal sequence located at the 5ʹ untranslated region
(5ʹ-UTR) of the mRNA, known as the Internal Ribosome Entry Site
(IRES) (Au and Jan, 2014; Komar et al., 2012; Niepmann, 2009).
This element promotes the direct interaction of preinitiation
complexes, or even 40S ribosomal subunits, to an internal region
of the mRNA leader sequence that can be followed by scanning
until the initiation codon is reached (Au and Jan, 2014; Chamond
et al., 2014). The number of eIFs that participate in this initiation
mechanism, as well as the molecular events that occur to build up
the 80S initiation complex, depends on the particular IRES
analyzed. Yet another mechanism of translation has been observed
with Sindbis virus (SINV) subgenomic mRNA (sgmRNA), which
contains a cap structure and is translated by a scanning mechan-
ism of its leader sequence, where cap recognition and linear
scanning are accomplished without the participation of crucial
eIFs, such as eIF2 or eIF4A (Garcia-Moreno et al., 2014). SINV
belongs to the alphavirus genus in the Togaviridae family and
contains a positive-stranded RNA as genome, which is delivered to
the cytoplasm after virus entry (Brown and Hernandez, 2012;
Schlesinger and Schlesinger, 1996; Strauss and Strauss, 1994). This
genomic mRNA (gmRNA) directs the synthesis of early nonstruc-
tural proteins (nsP1-4), which are involved in RNA replication and
transcription. In contrast, the sgmRNA is transcribed and trans-
lated in the late phase of the virus life cycle and gives rise to the
production of structural proteins concomitant with the inhibition
of cellular mRNA translation (Sanz et al., 2014). Interestingly, SINV
sgmRNA exhibits a dual mechanism of translation depending on
the context in which it is translated. Thus, translation of this mRNA
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does not require eIF2, eIF4G nor eIF4A in infected cells (Castelló
et al., 2006; Garcia-Moreno et al., 2013; Sanz et al., 2009; Ventoso
et al., 2006). In contrast, these factors are necessary to initiate
protein synthesis on sgmRNA in cell free systems or in trans-
fected cells.
Inhibitors of cellular functions are very valuable as therapeutic
agents, but they also represent important tools to help unravel the
molecular events involved in a given cellular or viral process. This
is the case for translation inhibitors, which have been widely
employed to explore the processes of mRNA translation (Lindqvist
and Pelletier, 2009; Vázquez, 1979). More recently, high through-
put screening methods have led to the discovery of a number of
new translation inhibitors with promising applications in mole-
cular biology (Cencic et al., 2011, 2012). One such molecule is
pateamine A (Pat A), a natural marine compound synthesized by
the sponge Mycale sp. (Hood et al., 2001; Low et al., 2007). Pat A
targets eIF4A and enhancing its helicase and ATPase activities
disrupts its interaction with eIF4G while promoting the formation
of a stable complex between eIF4A and eIF4B (Bordeleau et al.,
2005, 2006; Low et al., 2005). This disruption may lead to an
inhibition of the interaction of the preinitiation complexes with
mRNA (Bordeleau et al., 2006), or to the stalling of initiation
complexes at the leader region of mRNA in vitro (Low et al., 2005).
Thus, translation of capped mRNAs that require the eIF4F complex
is blocked. In contrast, hepatitis C virus (HCV) mRNA is not
inhibited by Pat A, although other mRNAs bearing picornavirus
IRES elements are blocked by this compound (Bordeleau et al.,
2006; Low et al., 2005). Additionally, Pat A induces the formation
of stress granules (SG) by a pathway independent of eIF2α
phosphorylation (Dang et al., 2006). In the present work, we have
tested the activity of Pat A on the translation of SINV gmRNA and
sgmRNA, both of which contain a cap-structure at the 5ʹ end. Our
results show that protein synthesis directed by sgmRNA is resis-
tant to Pat A inhibition, whereas gmRNA translation is blocked.
Moreover, resistance of sgmRNA to Pat A is only observed in SINV-
infected cells, but not when this mRNA is translated out of the
infection context. This represents the ﬁrst example of a capped
mRNA that is resistant to Pat A.
Results
Early translation of SINV gmRNA. Inhibition of nsP synthesis by Pat A
The ﬁrst step in the SINV replication cycle after virus entry is
the translation of the input gmRNA that has been delivered to the
cytoplasm (Hernandez et al., 2014). The schematic representation
of gmRNA, sgmRNA and the different constructs used in this work
are shown in Fig. 1a. To analyze the action of Pat A on translation,
BHK cells were initially infected with SINV for 1 h to allow virus
entry. Then, increasing amounts of the inhibitor were added and
cells were incubated for one additional hour. Synthesis of nsP1and
nsP2 was analyzed by immunoblotting using speciﬁc polyclonal
antibodies. Used at a concentration of 100 nM, Pat A markedly
inhibited the synthesis of nsP1 and nsP2 (Fig. 1b and c). Next,
translation of gmRNA was assayed by transfection of a non-
replicative RNA lacking most of the coding region of nsP4 and
bearing the luciferase gene embedded within the nsP3 sequence
(see SV-Luc ΔnsP4 scheme in Fig. 1a). Synthesis of luciferase
directed by this mRNA was strongly inhibited by Pat A in
transfected BHK cells (Fig. 1d). The extent of inhibition was similar
to that observed with a control cap-Luc mRNA, whereas synthesis
of luciferase directed by CrPV IGR-Luc mRNA was moderately
stimulated by Pat A. The cap-Luc contains the cellular leader
sequence of luciferase mRNA, while CrPV IGR IRES has the
intergenic region (IGR) from cricket paralysis virus (CrPV) genome
that confers translatability in the absence of any eIFs (Jan and
Sarnow, 2002). This ﬁnding indicated that Pat A has no effect on
the elongation or termination steps of translation and is consistent
with the idea that Pat A is a selective inhibitor of eIF4A. Therefore,
SINV gmRNA requires this initiation factor for its translation early
during infection.
To further analyze the synthesis of nsPs and to test the
formation of SG by Pat A, BHK cells were treated with Pat A or
sodium arsenite, an inducer of oxidative stress, and immunocy-
tochemistry was used to analyze SG formation. Treatment of
control uninfected BHK cells with Pat A (400 nM) resulted in
TIA-1 release from the nucleus to the cytoplasm and stimulated
formation of SGs at a level similar to that observed with sodium
arsenite (Fig. 2). As expected, the synthesis of nsP2 was dimin-
ished by Pat A in SINV infected cells, as assessed by reduced
staining with an antibody against nsP2 (Fig. 2). The amount of
nsP2 observed in presence of 200 μM sodium arsenite may
correspond to partial inhibition by this compound. Formation of
SG was abrogated in SINV-infected cells at 3 h post infection (hpi),
perhaps due to the production of nsP3 before treatment with the
inhibitors (Panas et al., 2012).
Previous observations indicated that Pat A blocks eIF4A in an
irreversible manner (Bordeleau et al., 2005; Low et al., 2005). Thus,
we tested the potential irreversibility of Pat A inhibition directly
on protein synthesis in SINV infected cells in order to assess the
blockade of other steps of SINV replication, such as the synthesis of
late viral proteins. To this end, BHK cells were infected with SINV
(10 pfu/cell) and cells were treated from 2 to 3 hpi with 200 nM
Pat A. Subsequently, the inhibitor was extensively washed out and
cells were replenished with fresh medium and protein synthesis
monitored for several hours after washing. As shown in Fig. 3, the
application of Pat A in uninfected cells for only 1 h potently
blocked cellular mRNA translation even several hours after wash-
ing off the inhibitor. On the other hand, Pat A strongly blocked the
remaining cellular mRNA translation, and also late viral proteins in
SINV-infected BHK cells treated from 2–3 hpi. This blockade
extended over the ensuing hours even in the absence of Pat A,
demonstrating that this compound exerts an irreversible inhibi-
tion of translation.
Translation of SINV sgmRNA to produce late viral proteins. Action of
Pat A
Viral RNA replication gives rise to the negative-stranded RNA,
which contains two promoters: one located at the 3ʹ-end and one
located internally. Viral transcription using this internal promoter
on negative RNA generates sgmRNA. Translation of this messenger
gives rise to the structural viral proteins, which are synthesized as
a large precursor that is proteolytically cleaved to render the
mature viral proteins. The initiation of translation of sgmRNA at
late stages of infection is carried out by a mechanism that does not
require certain eIFs (Garcia-Moreno et al., 2013, 2014; Sanz et al.,
2009, 2013). The inhibition of the synthesis of SINV structural
proteins was examined by radioactive labeling from 5 to 6 hpi
using different concentrations of Pat A. Translation of cellular
mRNAs was blocked by 32.5% with 100 nM Pat A and this
inhibition increased to 70% with 200 nM Pat A (Fig. 4a and b). At
these concentrations, the translation of SINV sgmRNA was only
marginally affected and a concentration of 400 nM Pat A was
required to provoke a reduction of viral protein synthesis of 50%.
However, this inhibition may not have been due solely to the
blockade of eIF4A activity, but perhaps also to side-effects of the
inhibitor on other cellular functions. Nevertheless, it can be
concluded that a concentration of Pat A that reduced cellular
protein synthesis by approximately 70% inhibited SINV sgmRNA
translation by only 20%, suggesting that initiation of translation
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of this viral messenger does not require eIF4A or intact eIF4F
complex at later times of the viral life cycle. Of note, the inhibition
of endogenous translation was less efﬁcient when compared with
transfected cap-Luc mRNA (Fig. 1c). This result is consistent with
the idea that disruption of the eIF4F complex has a greater impact
on de novo translation of mRNAs as compared to protein synthesis
directed by preexisting mRNAs already engaged in the polysome
(Novoa and Carrasco, 1999).
As with most alphaviruses, SINV is an arthropod borne virus
(arbovirus) that has two natural hosts for its transmission. Thus,
aside from vertebrate cells, SINV also infects insect cells, giving rise
to a productive infection without apparent inhibition of host
protein synthesis. Therefore, we next explored the action of Pat
A on translation in mosquito C6/36 cells infected of SINV (10 pfu/
cell) and treated with different concentrations of the compound.
As a control, the activity of Pat A was also examined in uninfected
Fig. 1. Translation of SINV gmRNA. Effect of Pat A. (a) Schematic representation of the RNAs employed in this work. (b) BHK cells were mock-infected or infected with SINV at
a multiplicity of infection (MOI) of 10 pfu/cell. At 1 hpi, cells were treated with vehicle or Pat A for 1 h at the indicated concentrations. SINV proteins nsP2 (upper panel) and
nsP1 (lower panel) were analyzed by western blot. The results shown are representative of three independent experiments. (c) Densitometric values of western blots of the
viral proteins nsP1 and nsP2 are expressed as the percentage of untreated samples. The results represent the mean7SD of three independent experiments. (d) In vitro
synthesized RNAs gmRNA SV-Luc ΔnsP4, RNA cap-Luc and CrPV IGR-Luc were transfected into BHK cells with Lipofectamine 2000. Different concentrations of Pat A (50, 100,
200 and 400 nM) or cycloheximide (100 mg ml1) were added at 1 hpt and cells were incubated for 1 h before analysis of luciferase activity. Values obtained from
cycloheximide-treated cells were used to subtract the amount of luciferase synthesized prior to Pat A addition. Luciferase activity values of Pat A-treated cells are expressed
as percentage of untreated samples. The results represent the mean7SD of three independent experiments.
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mosquito cells. Analogous to vertebrate cells, protein synthesis
was also inhibited by Pat A in insect cells (Fig. S1). In contrast,
sgmRNA translation at 7 hpi was more resistant to inhibition by
Pat A than cellular protein synthesis, even though the shut-off of
host translation does not occur in mosquito cells. Therefore, the
translation of sgmRNA appears to be more eIF4A/eIF4F-dependent
in insect cells than in vertebrate settings. This result indicates that
the resistance to Pat A in infected cells is speciﬁc for sgmRNA
translation and does not occur with other mRNAs that are
translated in the same cell.
It should be possible that Pat A resistance of SINV sgmRNA was
due to the fact that it is synthesized in large amounts from SINV
replicons and that these newly-synthesized mRNAs are located in
speciﬁc foci in close proximity to components of the protein
synthesizing machinery (Sanz et al., 2009). To test this possibility,
the sequence of luciferase gene preceded by a cellular IRES
element was cloned in place of SINV sgmRNA (see rep BiP-Luc
scheme Fig. 1a). The sgmRNA that is rendered after transfection of
rep BiP-Luc bears the IRES from the cellular mRNA that encodes for
the chaperone BiP (binding immunoglobulin protein). Translation
of this mRNA is independent of eIF2α phosphorylation (Fernandez
et al., 2002) and therefore can be translated in BHK cells that
replicate SINV RNA. Interestingly, Pat A strongly blocked luciferase
synthesis directed by this mRNA, indicating that it requires eIF4A
for translation under these conditions (Fig. 5). As a control SINV
rep Cþ luc was tested. In this case, the inhibition of sgmRNA
translation by Pat A was lower as compared to rep BiP-Luc.
Luciferase synthesis was assayed by measuring its activity
(Fig. 5). In conclusion, only protein synthesis directed by SINV
sgmRNA was resistant to Pat A, whereas under the same condi-
tions translation driven by a cellular IRES was sensitive to this
inhibitor.
Pat A inhibits sgmRNA translation out of the viral infection context
We next questioned whether the resistance of sgmRNA trans-
lation to Pat A was an intrinsic property of the RNA structure or
whether such a resistance was due to conditions existing in cells
Fig. 2. Pat A-induced formation of stress granules. Blockade by SINV infection. BHK cells seeded on glass coverslips were mock-infected or infected with SINV (MOI of 10 pfu/
cell). At 2 hpi, cells were treated or not with Pat A (400 nM) or sodium arsenite (200 mM) for 1 h. At 3 hpi, cells were ﬁxed, permeabilized and processed for
immunoﬂuorescence using anti-TIA-1 (red), anti-nsP2 (green) and DAPI (blue). Images were acquired with a confocal microscope and subsequently processed with Zeiss Zen
2010B sp1 and Zen 2008 software (Zeiss). Merged images show the simultaneous visualization of TIA-1, nsP2 and nucleic acids. Scale bar represents 30 mm. The results
shown are representative of three independent experiments.
E. González-Almela et al. / Virology 484 (2015) 41–5044
replicating SINV RNA. Initially, different mRNAs, including
sgmRNA, were transfected into BHK cells and luciferase synthesis
was measured after addition of increasing concentrations of Pat A.
Cycloheximide was added at the same time and served to establish
the amount of luciferase synthesized before the addition of Pat A,
and this was subtracted from these samples. As positive controls of
Fig. 3. Pat A blocks protein synthesis in an irreversible manner. (a) BHK cells were infected with SINV at a MOI of 10 pfu/cell for 1 h. Cells were then treated or not with Pat A
(200 nM) from 1 to 2 hpi. Subsequently, Pat A was washed out and replaced by fresh medium. At the indicated times, cells were labeled with [35S]MetCys for 1 h.
Radiolabeled proteins were separated by SDS-PAGE, followed by autoradiography. The results shown are representative of three independent experiments. (b) The
percentage of cellular (actin) and (c) viral C protein synthesis in cells treated or not with Pat A (200 nM) were calculated from values obtained by densitometric scanning of
the corresponding bands. The results are mean7SD of three independent experiments.
Fig. 4. Action of Pat A on the translation of SINV sgmRNA. (a) BHK cells were either mock-infected or infected with SINV (MOI of 10 pfu/cell). From 5 to 6 hpi, cells were
treated or not with the indicated concentrations of Pat A while they were labeled with [35S]MetCys. Radiolabeled proteins were separated by SDS-PAGE, followed by
autoradiography. The results shown are representative of three independent experiments. (b) Values of cellular and viral protein synthesis were obtained by densitometric
scanning of the radioactive signal and are expressed as the percentage of untreated samples. The results represent the mean7SD of three independent experiments.
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mRNAs that utilize eIF4A, we employed the eIF4A-dependent cap-
Luc and IRES EMC-Luc mRNAs. CrPV IGR-Luc and IRES HCV-Luc
mRNAs served as negative controls as these are not dependent on
eIF4A for initiation. As shown in Fig. 6a, SINV sgmRNAwas blocked
by Pat A in transfected BHK cells to an extent similar to that
observed with cap-Luc mRNA, while CrPV IGR-Luc and IRES HCV-
Luc mRNAs were in fact stimulated by Pat A. This stimulation was
presumably due to the fact that the inhibition of cellular mRNA
translation avoids the competition with translation driven by CrPV
or HCV IRES. In contrast, IRES EMC-Luc mRNA was partially
inhibited by Pat A, in agreement with in vitro results (Bordeleau
et al., 2005; Low et al., 2005). Further evidence that Pat A could
inhibit sgmRNA translation out of the context of active infection
was obtained through in vitro translation assays using rabbit
reticulocyte lysates (RRL). Increasing concentrations of Pat A
inhibited in vitro translation directed by sgmRNA CþLuc as well
as by cap-Luc or IRES EMC-Luc mRNAs (Fig. 6b). Interestingly, the
optimal translation of sgmRNA CþLuc required high concentra-
tions of KCl (Fig. 6c), as occurs with a variety of viral mRNAs which
are translated late during infection (Koch et al., 1980). Moreover,
the inhibition of sgmRNA CþLuc translation by Pat A was higher at
the optimal concentration of KCl (Fig. 6c). Collectively, these
ﬁndings indicate that the structure of sgmRNA is not responsible
for its resistance to inhibition by Pat A in infected cells; instead,
this viral messenger requires eIF4A for initiation of protein synth-
esis in uninfected cells.
Determination of the stage during SINV infection when translation
becomes resistant to eIF4A
To further assess the activity of Pat A on sgmRNA translation in
BHK cells that replicate SINV RNA, we made use of rep CþLuc (see
scheme, Fig. 1a). This SINV replicon was ﬁrstly synthesized by
in vitro transcription from the corresponding plasmid. After
transfection of rep CþLuc, C protein was analyzed at two distinct
time points in order to assess viral C production early during the
late phase or at later times. The activity of Pat A on the production
of C protein from 3 to 5 or from 6 to 8 h post transfection (hpt) was
estimated by western blotting using speciﬁc rabbit polyclonal
antibodies (Fig. S2). As a control, we measured in parallel the
amount of protein C synthesized prior to Pat A treatment by
adding cycloheximide. Surprisingly, 100 nM Pat A was strongly
inhibitory (91%) for C production at early times of the late phase,
whereas this inhibition was lower (20%) as replication progressed
(Fig. S2). These ﬁndings suggested that sgmRNA translation
requires eIF4A at early times and becomes less dependent on this
factor at later infection times.
Additionally, the above results indicated that gmRNA transla-
tion was sensitive to inhibition by Pat A very early during SINV
infection (Fig. 1), whereas at late times sgmRNA translation was
more resistant to the inhibition of eIF4A (Fig. 4). This behavior of
sgmRNA to Pat A only occurs in SINV-infected cells or in cells
replicating SINV RNA (Fig. S2), suggesting that when viral infection
progresses there is a switch from a mechanism of initiation of
protein synthesis dependent on eIF4A to a mode of translation that
is less dependent of this factor. To determine more accurately
when this switch takes place, SINV-infected cells were treated
with 200 nM Pat A at different hpi and protein synthesis was
analyzed by radioactive labeling followed by SDS PAGE and
ﬂuorography. During the initial hours of infection, cellular transla-
tion was potently blocked by Pat A (Fig. 7a and b). Conversely, the
synthesis of viral C protein was observed from 2 hpi and was
concomitant with the increased shut-off of cellular protein synth-
esis. Notably, from 2–3 and 3–4 hpi, the synthesis of C protein was
drastically reduced by Pat A, whereas from 4 hpi sgmRNA transla-
tion became more resistant to the inhibitor (Fig. 7a–c). Therefore,
at early periods during the late phase sgmRNA translation was
sensitive to Pat A, suggesting that a change occurs after that time
which confers less dependency on eIF4A for the initiation of
translation of sgmRNA in infected cells (Fig. 7c). Thus, Pat A
constitutes a good tool for future studies to investigate the
molecular nature of this switch. Further support to the concept
that sgmRNA translation is more dependent on eIF4A at early
times of the late phase was obtained by hippuristanol, the other
selective inhibitor of eIF4A (Garcia-Moreno et al., 2013). Indeed,
analysis of the inhibition of sgmRNA translation at different times
p.i. by hippuristanol clearly indicates that this inhibition varies and
becomes more resistant as infection progresses (Fig. S3).
Discussion
From the perspective of therapeutic agents and molecular tools,
marine organisms are providing a very interesting number of natural
compounds for investigation (Singh and Pelaez, 2008; Stonik and
Fedorov, 2014; Vera and Joullié, 2002). Since the discovery of didem-
nins, the ﬁrst marine natural products administered to humans (Lee
et al., 2012), the number of new inhibitors of cellular functions from
marine sources continues to rise (Skropeta and Wei, 2014). This is the
case for hippuristanol and Pat A, two natural compounds produced by
invertebrate marine organisms (Lindqvist and Pelletier, 2009). These
Fig. 5. Luciferase synthesis from rep CþLuc and rep BiP-Luc. Action of Pat A. BHK cells were transfected with in vitro synthesized RNAs rep CþLuc and rep BiP-Luc with
Lipofectamine 2000. Different concentrations of Pat A (25, 50 and 100 nM) or cycloheximide (100 μg ml1) were added at 5 hpt and cells were incubated for 2 h before
analysis of luciferase activity. Values obtained from cycloheximide-treated cells were used to subtract the amount of luciferase synthesized prior to Pat A addition. Luciferase
activity values of Pat A-treated cells are expressed as percentage of untreated samples. The RLU values obtained once the luciferase obtained in presence of cycloheximide
was subtracted were rep CþLuc: 48644047359965.9; rep BiPþLuc: 15918187135304.5. These luciferase values were taken as 100% of control. The results represent the
mean7SD of three independent experiments.
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Fig. 6. Translation of sgmRNA outside the viral infection context. Activity of Pat A. (a) In vitro synthesized sgmRNA CþLuc and control RNAs eIF4A-dependent (RNA cap-Luc
and IRES EMCV-Luc (left panel)) and eIF4A-independent (IRES HCV-Luc and CrPV IGR-Luc (right panel)) were transfected into BHK cells with Lipofectamine 2000. Cells were
then incubated with different concentrations of Pat A (50, 100, 200 and 400 nM) or cycloheximide (100 μg ml1) for 1 h before analysis of luciferase activity. Values obtained
from cycloheximide-treated cells were used to subtract the amount of luciferase synthesized prior to Pat A addition. Luciferase activity values of Pat A-treated cells are
expressed as percentage of untreated samples. The results are mean7SD of three independent experiments. (b) CrPV IGR-Luc (upper panel), sgmRNA CþLuc (medium
panel) and RNA cap-Luc (lower panel) were generated by in vitro transcription using T7 RNA polymerase and then, in vitro translated using nuclease-treated rabbit
reticulocyte lysate (RRL), programmed with 200 ng of the different mRNAs. Luciferase activity values of Pat A-treated cells are expressed as percentage of untreated samples.
The results are mean 7 SD of three independent experiments. (c) Effect of potassium [Kþ] on in vitro translation of sgmRNA CþLuc and its inhibition by Pat A. In vitro
transcribed sgmRNA CþLuc (200 ng) was translated in RRL at different concentrations of [Kþ] (80, 100, 120, 140, 160 and 180 mM) and treated or not with 200 nM of Pat A.
Luciferase activity results are mean7SD of three independent experiments. The percentage values of Pat A-treated cells relative to their respective untreated cells are
indicated in the ﬁgure.
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agents selectively inhibit the initiation of protein synthesis by targeting
eIF4A, thus blocking the activity of the eIF4F complex. These inhibitors
can be useful to ascertain the participation of eIF4A in the translation
of some cellular and viral mRNAs. As reported in this work, Pat A
strongly blocks the synthesis of SINV nsPs when used at early times
post infection. This inhibition of viral translation is irreversible such
that treatment for only 1 h is sufﬁcient to block the synthesis of viral
proteins at late times, as well as the inhibition of cellular translation.
The arrest of late viral protein synthesis is most likely due to the
inhibition of viral RNA replication and transcription that is accom-
plished by nsPs. Therefore, we can conclude that SINV gmRNA requires
eIF4A for translation and the blockade of nsP synthesis abrogates the
production of sgmRNA. The possibility that Pat Amay affect other steps
different to initiation is not supported by the ﬁnding that translation
driven by the CrPV IRES is not only resistant, but is actually stimulated
by Pat A, indicating that the elongation or termination processes of
mRNA translation are not affected by this compound. The stimulation
of CrPV IRES translation by Pat A may be a consequence of the
inhibition of cellular protein synthesis and the concomitant release
from mRNA competition. However, it is formally possible that Pat A
affects other cellular functions, such as the redistribution of nuclear
proteins, and that these reactions may affect sgmRNA translation at
high concentrations of Pat A. The potential repercussions of these
alterations for protein synthesis remains to be investigated, but we
believe that the most important activity of Pat A on mRNA translation
is its selective interaction with eIF4A, leading to the disruption of the
eIF4F complex (Bordeleau et al., 2005; Low et al., 2005).
The results obtained with Pat A on the translation of SINV sgmRNA
reinforce the view that eIF4A and the eIF4F complex are dispensable
in infected cells (Castelló et al., 2006; Garcia-Moreno et al., 2013; Sanz
et al., 2009). Thus, at concentrations of 200 nM Pat A there is a
profound inhibition of cellular translation, while sgmRNA is only
slightly blocked. Curiously, as observed with other translation inhibi-
tors, protein synthesis directed by sgmRNA is negatively affected out
of the replication complex (Garcia-Moreno et al., 2013). Therefore, our
present results with Pat A are consistent with the concept that this
messenger exhibits a dual mechanism for its translation and conse-
quently the structure of sgmRNA does not confer independence for
several eIFs (Sanz et al., 2009). This has been also clearly established
for the requirement of eIF2. In this case, there is a stem-loop structure
downstream of the AUG initiation codon (DLP) that confers eIF2
independence, but only in infected cells (Garcia-Moreno et al., 2013,
2014; McInerney et al., 2005; Ventoso et al., 2006). However, this DLP
structure is not involved in providing independence for eIF4A (Garcia-
Moreno et al., 2013). The structural requirements necessary for eIF4A-
independent translation of sgmRNA remain to be investigated.
SINV infected cells undergo a drastic modiﬁcation during infection,
from a Pat A-sensitive status at early times to a more resistant status
during the late phase of the viral cycle. Our kinetic analyses indicate
that this change occurs at about 4 hpi. From this time onwards,
translation of sgmRNA becomes independent of several eIFs, including
the eIF4F complex. Future studies will be needed to determine the
precise modiﬁcations that take place in SINV-infected cells to alter the
mechanism of initiation of translation.
Methods
Cell lines and viruses
The cell lines used in this work were Baby hamster kidney
(BHK-21) cells and Aedes albopictus C6/36 cells, both obtained from
Fig. 7. Time-course of Pat A resistance of sgmRNA translation. (a) BHK cells were infected with SINV (MOI of 10 pfu/cell). At the indicated times post infection, cells were
treated with vehicle or Pat A for 1 h at a concentration of 200 nM while they were labeled with [35S]MetCys. Radiolabeled proteins were separated by SDS-PAGE, followed
by autoradiography. The results shown are representative of three independent experiments. (b) The percentage of cellular (actin) and viral C protein synthesis in cells
treated or not with Pat A (200 nM) were calculated from values obtained by densitometric scanning of the corresponding bands. The results are mean7SD of three
independent experiments. (c) Inhibition of Pat A on viral C protein is represented as the percentage of corresponding untreated samples. These results represent the
mean7SD of three independent experiments.
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ATCC. BHK-21 cells were grown at 37 1C, 5% CO2 in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 5% fetal calf
serum (FCS). C6/36 cells were cultured at 28 1C without CO2 in M3
medium supplemented with 10% FCS. SINV derived from the
pT7SVwt infective clone was used (Sanz and Carrasco, 2001). Viral
infections of BHK-21 cells were carried out in DMEM without
serum for 1 h at 37 1C, whereas infections of C6/36 cells were
performed at 28 1C. Subsequently, medium was removed and
infection was continued in DMEM with 5% FCS or M3 medium
with 10% FCS, respectively, at the temperatures indicated. Infec-
tions with SINV were carried out at a multiplicity of 10 pfu per cell.
Plasmids and recombinant DNA procedures
The plasmids employed in this work are listed and described in
Table S1. Plasmids were used as DNA templates for in vitro
transcription with T7 or Sp6 RNA polymerases. pT7 SVwt (Sanz
and Carrasco, 2001) was used as the parental plasmid for all of the
constructs. The luciferase gene was derived from the plasmid pKS-
Luc (Sanz et al., 2007).
Plasmid rep Bip-Luc was prepared with a product obtained after
two consecutive PCRs between HpaI and SphI sites in rep Cþ luc. In the
ﬁrst PCR, oligonucleotides 50 HpaI (5ʹ-GCTATGGCGTTAACCGGTCTG-3ʹ)
and 30 Nexo SV-Bip (5ʹ-GGCCGGCGTCGACCTGCTGACTATTTAGG-3ʹ)
were used plus rep C+luc as DNA template. The other PCR product
was obtained using 50 Nexo SV-Bip (5ʹ-CCTAAATAGTCAGCAGGTC-
GACGCCGGCC-3ʹ) and 30 Luc SphI (5ʹ-CCCGGGGCATGCGAGAATCT-
GACGCAG-3ʹ) oligonucleotides plus pBS-BIP-IRES-FFL-pA as DNA
template, kindly provided from Dr. M. Hentze (EMBL Heidelberg,
Germany). Oligonucleotides 50 HpaI and 30 Luc SphI with a mixture
of the above products as DNA template were employed in the
next PCR.
Antibodies
Rabbit polyclonal antibodies raised against SINV C protein and
rat polyclonal antibodies raised against bacterially produced nsP1
were produced in our laboratory. Rabbit polyclonal anti-nsP2 was
a kind gift from Dr. Richard W Hardy (Indiana University, USA).
Goat polyclonal anti-TIA-1 was purchased from Invitrogen and
Santa Cruz Biotechnology. Anti-rabbit and anti-rat immunoglobu-
lin G antibodies coupled to peroxidase were purchased from
Amersham. Speciﬁc antibodies conjugated to Alexa 488 or Alexa
555 (A-21202 and A-21432 respectively) were obtained from
Invitrogen.
Inhibitors
The following chemical inhibitors were used: pateamine A was
puriﬁed as previously described (Bordeleau et al., 2005), hippur-
istanol (Bordeleau et al., 2006), sodium arsenite (Riedel-de Haën)
and cycloheximide (Sigma).
In vitro RNA transcription and translation
Linearized plasmids were used as templates for in vitro RNA
transcription using T7 or SP6 RNA polymerases (New England
Biolabs), as previously described (Garcia-Moreno et al., 2013).
In vitro translation was carried out in nuclease-treated rabbit
reticulocyte lysate (RRL) (Promega). One hundred nanograms of
in vitro transcribed mRNAs were added to the translation mixture.
Protein synthesis was estimated by measuring luciferase activity.
RNA transfection
In vitro transcribed RNAs were transfected using Lipofectamine
2000 (Invitrogen) according to the supplier's recommendations.
Measurement of luciferase activity
Luciferase activity was determined as described by Sanz et al.
(2014).
Analysis of protein synthesis and western blotting
Protein synthesis was analyzed at the indicated times by
replacing growth media for 1 h with 0.2 ml of methionine/
cysteine-free DMEM supplemented with 1 μl of EasyTagTM
EXPRESS 35S Protein Labeling, [35S]MetCys (11 mCi ml1, Perkin
Elmer) per well of an L-24 plate. Labeling medium also included
inhibitors when the action of these compounds was assayed.
Radioactive proteins and samples for western blotting were
analyzed as described (Garcia-Moreno et al., 2013). Protein synth-
esis was quantiﬁed by densitometry using a GS-800 Calibrated
Densitometer (Bio-Rad).
Immunoﬂuorescence assays
Fixation, permeabilization and confocal microscopy were per-
formed as described (Madan et al., 2008) using a confocal laser
scanning and multiphoton microscope LSM 710 coupled to an
inverted microscope (Axio Observer, Zeiss). Primary antibodies
used were: rabbit polyclonal anti SINV nsP2, and goat polyclonal
anti-TIA-1 at a 1:500 dilution. Speciﬁc antibodies conjugated to
Alexa 488 and Alexa 555 were employed as secondary antibodies
at a 1:1000 dilution. DAPI (4ʹ-6-diamidino-2-phenylindole) was
used to stain the nuclei.
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